Royce & Associates LP Acquires 18,091 Shares of Azenta, Inc. (NASDAQ:AZTA)

Royce & Associates LP grew its holdings in shares of Azenta, Inc. (NASDAQ:AZTAFree Report) by 2.4% in the fourth quarter, HoldingsChannel reports. The fund owned 758,068 shares of the company’s stock after purchasing an additional 18,091 shares during the quarter. Royce & Associates LP’s holdings in Azenta were worth $37,903,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Picton Mahoney Asset Management grew its position in shares of Azenta by 305.7% during the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company’s stock valued at $35,000 after acquiring an additional 532 shares during the period. KBC Group NV grew its position in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after acquiring an additional 698 shares during the period. Assenagon Asset Management S.A. bought a new stake in shares of Azenta during the 4th quarter valued at $200,000. Aigen Investment Management LP bought a new stake in shares of Azenta during the 3rd quarter valued at $214,000. Finally, Catalyst Funds Management Pty Ltd grew its position in shares of Azenta by 123.0% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 4,684 shares of the company’s stock valued at $234,000 after acquiring an additional 2,584 shares during the period. Institutional investors own 99.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on AZTA shares. TD Cowen raised shares of Azenta to a “hold” rating in a research report on Thursday, February 27th. Stephens reaffirmed an “overweight” rating and issued a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Needham & Company LLC upped their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday, February 6th. Finally, Evercore ISI upped their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $58.75.

Get Our Latest Research Report on AZTA

Azenta Stock Up 0.7 %

AZTA opened at $36.80 on Friday. The firm has a 50-day simple moving average of $48.16 and a two-hundred day simple moving average of $47.05. Azenta, Inc. has a 52 week low of $35.90 and a 52 week high of $63.58. The company has a market capitalization of $1.68 billion, a PE ratio of -12.35 and a beta of 1.52.

Azenta (NASDAQ:AZTAGet Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, sell-side analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current year.

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Stories

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.